Cancer cell-derived TGF-β has been reported to modulate myofibroblast differentiation in colon and breast cancer [23, 24], suggesting that cancer-cell-derived TGF-β may also induce differentiation of fibrocytes into myofibroblasts. Here, TGFB1 is linked to breast carcinoma.